Vimta Labs Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Vimta Labs Ltd. on BSE

Load latest

Vimta Labs Ltd.

16 Apr 2024

1023.80

5.13%

Corp. Note

VIMTA LABS LTD.-$ - 524394 - Format of the Initial Disclosure to be made by an …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyVIMTA LABS LTD.- 2CIN NO.L24110TG1990PLC011977 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 14.05 4Highest Credit Rating during the previous FY Astable 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CARE RATINGS LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Sujani Vasireddi Designation: Company Secretary and Compliance Officer EmailId: shares@vimta.com Name of the Chief Financial Officer: Narahai Naidu D R Designation: Chief Financial Officer EmailId: cfo@vimta.com Date: 16/04/2024 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Vimta Labs Ltd.

15 Apr 2024

1023.80

5.13%

Company Update

VIMTA LABS LTD.-$ - 524394 - Compliance Certificate Under Regulation 7(3) For The Year Ended 31.03.2024.

BSE India

Compliance Certificate under Regulation 7(3) issued by Share Transfer Agent CIL Securities Limited for the year ended 31.03.2024.

pdf

Vimta Labs Ltd.

13 Apr 2024

1023.80

5.13%

Company Update

VIMTA LABS LTD.-$ - 524394 - Compliance Certificate Under Regulation 40(9)

BSE India

Compliance Certificate issued by Practicing Company Secretary for the year ended 31st March 2024

pdf

Vimta Labs Ltd.

13 Apr 2024

1023.80

5.13%

Company Update

VIMTA LABS LTD.-$ - 524394 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Confirmation Certificate provided by the share transfer agent M/s CIL SECURITIES LTD, for the quarter ended 31st March 2024.

pdf

Vimta Labs Ltd.

05 Apr 2024

1023.80

5.13%

Corp. Note

VIMTA LABS LTD.-$ - 524394 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

Loss of Share Certificate

pdf

Vimta Labs Ltd.

30 Mar 2024

1023.80

5.13%

Company Update

VIMTA LABS LTD.-$ - 524394 - Announcement under Regulation 30 (LODR)-Restructuring

BSE India

Approved Amalgamation of Emtac Laboratories Private Limited, wholly owned subsidiary Company with Vimta Labs Limited, Holding Company.

pdf

Vimta Labs Ltd.

30 Mar 2024

1023.80

5.13%

Board Meeting

VIMTA LABS LTD.-$ - 524394 - Board Meeting Outcome for Scheme Of Amalgamation Of Emtac Laboratories …

BSE India

Approval of Scheme of Amalgamation of Emtac Laboratories Private Limited, Wholly Owned Subsidiary Company with Vimta Labs Limited, Holding Company.

pdf

Vimta Labs Ltd.

27 Mar 2024

1023.80

5.13%

AGM

VIMTA LABS LTD.-$ - 524394 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

BSE India

Postal Ballot Voting Results and Scrutinizer''s Report

pdf

Vimta Labs Ltd.

26 Mar 2024

1023.80

5.13%

Corp. Note

VIMTA LABS LTD.-$ - 524394 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

Loss of Share Certificate.

pdf

Vimta Labs Ltd.

20 Mar 2024

1023.80

5.13%

Board Meeting

VIMTA LABS LTD.-$ - 524394 - Board Meeting Intimation for The Scheme Of Amalgamation

BSE India

VIMTA LABS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/03/2024 ,inter alia, to consider and approve the scheme of amalgamation of Emtac Laboratories Private Limited, Wholly Owned Subsidiary Company with Vimta Labs Limited,holding company.

pdf

Is Vimta Labs Ltd. worth buying?

71 Votes:

Buy 73.24%

Sell 15.49%

Hold 11.27%